Hand on Laptop
PACT logo

PACT Webinars


In collaboration with The Thoracic Society of Australia and New Zealand and the Centre of Research Excellence in Pulmonary Fibrosis, PACT runs a webinar series for health professionals.
Watch previous webinars on demand now. Stay tuned for future webinars.

Health Professional Webinars:

Accelerating translational research to find cure for IPF: Can we REMAP-ILD? 

Event Date: 11 November 2022 

This free webinar educated health professionals about a Randomised, Embedded, Multifactorial, Adaptive, Platform (REMAP) trial design for interstitial lung disease (ILD). Learn from an international expert about this project with the potential to change the landscape of clinical trials and the lives of people living with pulmonary fibrosis. 

Chair: Prof Tamera Corte 

Presenter: Prof Gisli Jenkins is an NIHR Research Professor and is Head of the Margaret Turner-Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute. Prof Jenkins’ research focuses on Interstitial Lung Diseases, and Pulmonary Fibrosis in particular. His team works to understand the biological basis for the development of pulmonary fibrosis and aims to translate this understanding in to improved outcomes for patients. He is the Principal Investigator of a number of longitudinal observational studies including the PROFILE study, the INJUSTIS Study, the UKILD Post COVID ILD study as well as the DEMISTIFI Multi-Morbidity consortium. Prof Jenkins was awarded the ERS Gold Medal in Interstitial Lung Disease in 2020. In 2022 he became a Fellow of the European Respiratory Society, and appointed President of Action for Pulmonary Fibrosis. 

Watch on demand long-arrow-right

Pragmatic trials and registry/EMR-based studies

Event Date: 16 September 2022 

This free webinar educated health professionals about pragmatic clinical trials and registry/electronic medical record-based studies. Learn from an international expert about testing treatments in the real world and harnessing the power of real world data. 

Chair: A/Prof Ian Glaspole 

Presenter: Prof David Price is a Primary Care Respiratory Society Professor of Primary Care Respiratory Medicine at the University of Aberdeen and Managing Director of Optimum Patient Care Global, Australia, and UK. He has authored over 888 peer-reviewed publications since 2000 with a H-index of 99 and is responsible for approximately US$75 million in research and clinical development grants. David’s work focuses on pragmatic clinical trials, real-life databases research, disease registries and quality improvement in primary and secondary care in conditions such as ILD, severe asthma and COPD, where he is an acknowledged global authority.

Watch on demand long-arrow-right

ATS 2022 Pulmonary Fibrosis in a Nutshell – What’s the latest in PF clinical research?

Event Date: 3 June 2022  

This free webinar allowed health professionals to catch up on the latest in clinical research in pulmonary fibrosis from the May 2022 ATS conference.   

Chair:  Prof Dan Chambers 

Presenter:  A/Prof Yet Khor is an NHMRC Emerging Leadership Fellow at Monash University, a physician at the Austin and Alfred Health Interstitial Lung Disease Services, and the Oxygen Service Lead at Austin Health. Her main research interests include risk prediction and disease burden management in interstitial lung disease.  

Watch on demand long-arrow-right

Planning for implementation using science and strategy

Event Date: 9 September 2021 

This webinar educated health professionals about the science and strategy of implementation in the context of clinical trials, including insights on planning for future implementation. Implementation is increasingly a focus of funding schemes, meaning that it’s a useful topic for clinical trialists and/or clinician-researchers in pulmonary fibrosis to upskill on! 

Chair: Prof Anne Holland 

Presenter: Prof Natasha A. Lannin (PhD, BSc, GCIS, FAOTA, FOTARA), Professor (Research), Department of Neuroscience, Monash University; and Clinical Chair (Research) – Occupational Therapy, Alfred Health. Prof Lannin is a clinical trialist with an extensive research track record in rehabilitation. Working within the Department of Neuroscience at Monash University, she conducts randomised trials investigating the effects of rehabilitation interventions and hybrid implementation studies investigating the translation of trial evidence into clinical practice. 

Watch on demand long-arrow-right

ATS recap – What’s the latest in pulmonary fibrosis clinical research?

Event Date: 11 June 2021 

This webinar caught health professionals up on the latest in clinical research in pulmonary fibrosis from the May 2021 ATS conference. 

The 2021 ATS was a virtual event and with the time difference between Australia-New Zealand and the USA, joining sessions live was a challenge! 

Chair: A/Prof Tamera Corte 

Presenter: A/Prof Ian Glaspole: A/Prof Ian Glaspole is the head of the Alfred Hospital interstitial lung disease clinic and an adjunct clinical associate professor within the Monash University Faculty of Medicine. His research focuses on interstitial lung disease, and has included numerous clinical trials exploring treatments for idiopathic pulmonary fibrosis, along with other clinical and laboratory based research, principally focused on improving the symptoms and quality of life of sufferers of these rare lung diseases. 

Watch on demand long-arrow-right

New drugs for pulmonary fibrosis – are there any blockbusters around the corner?

Event Date: 30 March 2021 

This webinar caught health professionals up on the latest in drug development and clinical trials in pulmonary fibrosis. 

It is so heartening to be able to speak optimistically about the future when we see our patients with IPF and other interstitial lung disease in the clinic. Not only do we have two approved drugs, but there are multiple potential breakthrough treatments in clinical development right now, many of them in late phase clinical trials. 

Chair: Prof Margaret Wilsher 

Presenters: Prof Glen Westall is a Consultant Chest Physician, and Head of the Paediatric Lung Transplant Program at the Alfred Hospital, Melbourne. He trained at King’s College, London; the Alfred Hospital, Melbourne and Royal Brompton Hospital, London. Glen oversees the basic scientific research portfolios of the Alfred’s lung transplant and lung fibrosis service. As an academic clinician, he has established a number of translational projects with industry partners that have taken discoveries in basic science to the clinical interface. In particular he has established biorepositories that collect and store both normal lung tissue and fibrotic lungs. 

Prof Dan Chambers is a thoracic and transplant physician with special interests in immunology and interstitial lung disease. Dan’s research focuses on the pathogenesis of lung fibrosis, new diagnostic methods and biomarkers, and therapeutic discovery. His research has been supported by > $15 million in competitive grant funding and he has authored more than 100 research papers. He has been a Principal Investigator for numerous clinical trials of all phases in interstitial and other lung diseases including IPF. Dan is Chair of the Pulmonary Fibrosis Australasian Clinical Trials Network (PACT). 

Watch on demand long-arrow-right

Consumer Webinars

Understanding Pulmonary Fibrosis Clinical Trials

Event date: 20 May 2021

In collaboration with Lung Foundation Australia and the Centre of Research Excellence in Pulmonary Fibrosis, PACT held a clinical trials webinar for consumers on Clinical Trials Day. The webinar provided an insight into Clinical Trials to help you gain an understanding into what it means to participate in research and a Pulmonary Fibrosis clinical trial.


  • Prof Dan Chambers is a Thoracic and Transplant Physician and Clinical Professor at the University of Queensland. He cared for many critically ill patients during the Swine Flu epidemic in 2009. His research focuses on severe lung disease and transplantation.
Watch on demand long-arrow-right